IBD: Tofacitinib effective in ulcerative colitis

Nature Reviews Gastroenterology and Hepatology

Volumn 14, Issue 7, 2017, Pages 388-

  Bradley, Conor A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TOFACITINIB; PIPERIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NOTE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; HUMANS; PIPERIDINES; PYRIMIDINES; PYRROLES;

EID: 85021318504     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2017.66     Document Type: Note

References (1)

1. Sandborn, W. J., et al. Tofacitinib as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 376, 1723-1736 (2017)